Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox

• Váldodahkkit: Iván Cervigón-González (Dahkki), Luis Miguel Torres-Iglesias (Dahkki), Ángel Palomo-Arellano (Dahkki), Braulio Gil-Pascual (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Karger Publishers, 2011-02-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Advanced-stage primary cutaneous T-cell lymphoma has an unfavorable prognosis and low survival rates. Aggressive treatment with chemotherapy is not curative and causes considerable side effects. The combination of bexarotene and denileukin diftitox is associated with an acceptable safety profile and...